Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody
about
Mapping biological behaviors by application of longer-lived positron emitting radionuclidesDual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysisComparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTAGeneration and screening of monoclonal antibodies for immunoPET imaging of IGF1R in prostate cancer.Image guided biodistribution and pharmacokinetic studies of theranostics.PET of follicle-stimulating hormone receptor: broad applicability to cancer imagingHaloTag: a novel reporter gene for positron emission tomography.A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT.Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody.In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene.Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2.Immuno-PET of tissue factor in pancreatic cancer.Tumor vasculature targeting and imaging in living mice with reduced graphene oxide.Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121.PET imaging of CD105/endoglin expression with a ⁶¹/⁶⁴Cu-labeled Fab antibody fragmentImmuno-PET of epithelial ovarian cancer: harnessing the potential of CA125 for non-invasive imagingImaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescenceTargeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.Chelators for copper radionuclides in positron emission tomography radiopharmaceuticalsRadiolabeling strategies for tumor-targeting proteinaceous drugs.Peptoid and Positron Emission Tomography: an Appealing CombinationMANOTA: a promising bifunctional chelating agent for copper-64 immunoPET.A Modular Dual Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting.Bifunctional (64)Cu-labelled macrobicyclic cage amine isothiocyanates for immuno-positron emission tomography.PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate.Positron emission tomography of 64Cu-DOTA-Rituximab in a transgenic mouse model expressing human CD20 for clinical translation to image NHL.PET and SPECT imaging of melanoma: the state of the art.
P2860
Q26824070-23F11B7E-F25E-4AFA-B916-B2C1D78E8F06Q27027682-8D99F936-2AEE-498F-B130-F33BAC0E83B9Q27339846-B3B2CE04-6C68-469E-A813-6D948D41EC64Q28741667-001D1801-6A5C-4FCC-BE9F-8AC89A78C67EQ34293602-C57034A7-BF82-4984-83E7-78D2CE540B9BQ34506838-FDD80BCF-1F0A-4DB3-9E47-C91E5602ECCDQ35153873-55A49730-DD1A-4D0E-B1F8-17710569D557Q35172566-FB9663E2-2DCA-485C-AFAE-A3E7B3024DA9Q35650526-24CAA5C4-65B8-4C44-B4D9-E6F8780AD653Q35809541-4FF3C848-5116-4E16-81B9-6ADFFF0BE3E8Q35856996-E062A98C-FEC6-4566-B3B2-4BBE138412F9Q36157472-60465AA3-5007-4286-A3B3-0CD196A585A6Q36374066-19397611-6E14-4972-9B48-32A2C6E8F803Q36604948-EEAA9AC1-5E61-4ADC-B59D-7DD1E1415D1CQ36746567-0D66CBC2-A5DC-4BEE-8AED-670B3FE45549Q36763112-97F35B17-0017-45C8-BA80-99E9214622D3Q36944360-158834B8-3283-4A77-907D-7DDCD7883A09Q36996613-928CE895-B28F-4235-B10A-1A8CF3B75CCCQ37624368-6421A9F1-FCBB-40B6-B8FA-F07A10A6A9D9Q38172069-D0B5E718-053A-4A06-BCEC-432E341BB8DBQ38189541-BA2E30F2-4C55-41CC-AFF1-FCCBDBB61024Q38595230-85A28D7A-CA48-4209-B7F6-70D3B828169DQ38693617-6B46EB16-8714-4924-B8CC-4363E6188B53Q38749965-34AC4D45-C612-4137-A352-CA405202E4EAQ38944485-29954E1D-BF50-4586-955A-C200CF827677Q39066068-29824340-4A66-447C-99E6-FF9A59EA4E65Q39414818-C78FB3BF-9BA6-4734-A8FB-D99F600D7FA0Q47868574-60E8B001-4701-4526-8854-2A607C9C4DF8
P2860
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Imaging cancer using PET--the ...... n of a (64)Cu-labeled antibody
@ast
Imaging cancer using PET--the ...... n of a (64)Cu-labeled antibody
@en
Imaging cancer using PET--the ...... or on the biodistribution of a
@nl
type
label
Imaging cancer using PET--the ...... n of a (64)Cu-labeled antibody
@ast
Imaging cancer using PET--the ...... n of a (64)Cu-labeled antibody
@en
Imaging cancer using PET--the ...... or on the biodistribution of a
@nl
prefLabel
Imaging cancer using PET--the ...... n of a (64)Cu-labeled antibody
@ast
Imaging cancer using PET--the ...... n of a (64)Cu-labeled antibody
@en
Imaging cancer using PET--the ...... or on the biodistribution of a
@nl
P2093
P2860
P1476
Imaging cancer using PET--the ...... n of a (64)Cu-labeled antibody
@en
P2093
Alan B Packard
Claude F Meares
Frederic Fahey
James S Huston
Jason L J Dearling
Patricia Dunning
S Ted Treves
Stephan D Voss
Suzanne V Smith
P2860
P356
10.1016/J.NUCMEDBIO.2010.07.003
P577
2010-10-27T00:00:00Z